From genome sequencing to the discovery of potential biomarkers in liver disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, Sumin | - |
dc.contributor.author | Jo, Yeeun | - |
dc.contributor.author | Jung, Sungju | - |
dc.contributor.author | Yoon, Sumin | - |
dc.contributor.author | Yoo, Kyung Hyun | - |
dc.date.available | 2021-02-22T05:24:31Z | - |
dc.date.issued | 2020-06 | - |
dc.identifier.issn | 1976-6696 | - |
dc.identifier.issn | 1976-670X | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/1471 | - |
dc.description.abstract | Chronic liver disease progresses through several stages, fatty liver, steatohepatitis, cirrhosis, and eventually, it leads to hepatocellular carcinoma (HCC) over a long period of time. Since a large proportion of patients with HCC are accompanied by cirrhosis, it is considered to be an important factor in the diagnosis of liver cancer. This is because cirrhosis leads to an irreversible harmful effect, but the early stages of chronic liver disease could be reversed to a healthy state. Therefore, the discovery of biomarkers that could identify the early stages of chronic liver disease is important to prevent serious liver damage. Biomarker discovery at liver cancer and cirrhosis has enhanced the development of sequencing technology. Next generation sequencing (NGS) is one of the representative technical innovations in the biological field in the recent decades and it is the most important thing to design for research on what type of sequencing methods are suitable and how to handle the analysis steps for data integration. In this review, we comprehensively summarized NGS techniques for identifying genome, transcriptome, DNA methylome and 3D/4D chromatin structure, and introduced framework of processing data set and integrating multi-omics data for uncovering biomarkers. | - |
dc.format.extent | 12 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY | - |
dc.title | From genome sequencing to the discovery of potential biomarkers in liver disease | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.5483/BMBRep.2020.53.6.074 | - |
dc.identifier.scopusid | 2-s2.0-85087110701 | - |
dc.identifier.wosid | 000545933200002 | - |
dc.identifier.bibliographicCitation | BMB REPORTS, v.53, no.6, pp 299 - 310 | - |
dc.citation.title | BMB REPORTS | - |
dc.citation.volume | 53 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 299 | - |
dc.citation.endPage | 310 | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002598605 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.subject.keywordPlus | SINGLE-NUCLEOTIDE-RESOLUTION | - |
dc.subject.keywordPlus | HEPATOCELLULAR-CARCINOMA | - |
dc.subject.keywordPlus | RNA-SEQ | - |
dc.subject.keywordPlus | WIDE ANALYSIS | - |
dc.subject.keywordPlus | DNA | - |
dc.subject.keywordPlus | REVEALS | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | TRANSCRIPT | - |
dc.subject.keywordPlus | SCALE | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordAuthor | Biomarker | - |
dc.subject.keywordAuthor | Integrative analysis | - |
dc.subject.keywordAuthor | Liver disease | - |
dc.subject.keywordAuthor | NGS techniques | - |
dc.identifier.url | http://www.bmbreports.org/journal/view.html?doi=10.5483/BMBRep.2020.53.6.074 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.